Not Yet Recruiting
Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer
NCT07630948
- Conditions
- Adherence, Medication, Behavior, Breast Cancer, +11 more
- Locations
-
- Institute of Oncology Ljubljana Ljubljana, Slovenia